Spinogenix

San Diego, United States

Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.

$2.8M raised

Jun 2024

Venture - Series Unknown

Top Investors

National Institutes of HealthU.S. Department of Defense

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Spinogenix raised?

Spinogenix has raised $2.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.

Who are Spinogenix's investors?

Spinogenix's investors include National Institutes of Health, U.S. Department of Defense.

Where is Spinogenix headquartered?

Spinogenix is headquartered in San Diego, United States.

What does Spinogenix do?

Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.

What stage is Spinogenix at?

Spinogenix is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 21, 2024.

MLA

"Spinogenix — Funding & Investors." VCBacked, June 21, 2024, https://www.vcbacked.co/company/spinogenix. Accessed June 4, 2026.

APA

VCBacked. (2024). Spinogenix — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/spinogenix

Wikipedia (cite web)

{{cite web |title=Spinogenix — Funding & Investors |url=https://www.vcbacked.co/company/spinogenix |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 21, 2024.